year
longstand
intens
relationship
base
mani
mutual
activ
becom
part
chines
german
medic
histori
exampl
dr
erich
paulun
german
doctor
work
shanghai
around
turn
centuri
found
first
deutsch
medizinschul
chinesen
german
medic
school
chines
later
medic
faculti
tongji
univers
shanghai
wuhan
tradit
germanbas
medicin
upheld
today
lead
student
educ
lectur
german
languag
germani
mani
chines
doctor
still
work
influenc
medic
develop
mani
field
tradit
chines
medicin
exampl
popular
germani
add
lot
stimul
idea
socal
western
medicin
due
polit
situat
period
silenc
begin
world
war
ii
polici
open
could
cooper
reestablish
step
step
strong
activ
side
field
anatom
surgic
patholog
recent
year
domin
intent
share
knowledg
skill
well
exchang
young
colleagu
exampl
telepatholog
project
initi
shanghai
chongch
berlin
support
nation
scienc
foundat
china
deutsch
forschungsgemeinschaft
give
activ
framework
author
german
chines
societi
patholog
agre
establish
continu
interact
eg
presenc
repres
annual
meet
societi
among
reason
reflect
dramat
increas
import
peopl
republ
china
scientif
commun
first
step
symposium
new
develop
surgic
basic
patholog
held
hangzhou
china
april
april
attend
symposium
lead
pathologist
countri
support
scienc
center
chair
professor
maod
lai
zhejiang
univers
china
professor
manfr
dietel
humboldt
univers
germani
meet
cover
comprehens
updat
recent
develop
surgic
basic
patholog
also
provid
gener
aspect
field
countri
intend
establish
forum
foster
commun
collabor
pathologist
china
germani
report
summaris
essenti
inform
meet
professor
heinz
technisch
germani
introduc
overal
aspect
molecular
patholog
germani
professor
dietel
gave
overview
dna
array
technolog
diagnost
patholog
technolog
may
provid
molecular
signatur
individu
tumour
potenti
power
indic
diagnosi
therapi
respons
prognosi
etc
becom
possibl
determin
biolog
behaviour
given
tumour
much
precis
exampl
predict
potenti
metastasis
resist
cytostat
drug
individu
prognosi
diagnost
genom
signatur
may
lead
new
approach
function
surgic
patholog
professor
lai
review
state
art
regard
proteom
cancer
research
briefli
mention
one
novel
protein
overexpress
colon
cancer
comparison
correspond
normal
colon
mucosa
adjac
mucosa
cancer
detect
electrophoresi
uptod
studi
group
proteom
colorect
cancer
professor
jie
zheng
peke
univers
china
show
group
extens
intens
studi
novel
genetumour
metastasisrel
gene
genebank
access
group
first
discov
gene
first
surrog
mrna
differenti
display
polymeras
chain
reaction
pcr
separ
four
prostat
cancer
cell
line
subclon
overexpress
two
subclon
low
invas
metastat
capac
previous
verifi
tumourigenesi
spontan
metastasi
nude
mice
fulllength
cdna
sequenc
obtain
via
sequenc
est
assembl
chromosom
locat
also
disclos
eventu
gene
reconfirm
northernblot
techniqu
four
cell
line
subclon
prime
situ
label
subclon
monoclon
antibodi
produc
use
standard
hybridoma
techniqu
semiquantit
reversetranscript
rt
pcr
six
common
human
cancer
reveal
express
level
highest
prostat
adenocarcinoma
grade
iv
recurr
poorli
differenti
breast
cancer
lowest
lung
cancer
nevertheless
higher
express
level
document
poorli
differenti
colon
adenocarcinoma
welldifferenti
cancer
strong
posit
signal
cytoplasm
stain
found
subclon
either
westernblot
immunocytochem
stain
contrast
neg
result
remain
breast
colorect
cancer
posit
stain
common
cancer
metastasi
without
metastasi
versu
breast
versu
colorect
biolog
effect
gene
transfect
two
prostat
cancer
cell
line
also
studi
transfect
sens
display
consider
suppress
cell
growth
curv
obvious
lower
outsid
diamet
od
ratio
mean
transit
time
reduc
clone
format
soft
agar
clone
format
assay
compar
vain
vector
nontransfect
transfect
antisens
exhibit
activ
cell
growth
higher
od
ratio
increas
clone
format
howev
cell
apoptot
rate
increas
sens
transfect
rel
invari
antisens
vain
vector
transfect
nontransfect
professor
weigang
fang
peke
univers
china
present
group
find
show
effect
agonist
adenosin
triphosph
atp
adenosin
monophosphatepurin
nucleosid
phosphorylas
antagonist
suramin
pd
sb
purinoreceptor
g
protein
coupl
receptor
mitogenactiv
extracellular
signalregul
kinaseactiv
kinas
mek
mitogenactiv
protein
kinas
mapk
signal
transduct
pathway
two
prostat
cancer
cell
line
metastat
nonmetastat
use
westernblot
method
activ
significantli
enhanc
atp
time
dosedepend
manner
cell
line
howev
effect
dramat
suppress
surman
pd
sb
indic
activ
could
incur
mekmapk
signal
transduct
pathway
furthermor
receptorinduc
activ
well
nfb
activ
found
higher
metastat
cell
nonmetastat
cell
impli
potenti
signal
mechan
regul
metastat
phenotyp
vitro
invas
assay
invas
cell
line
stimul
atp
parallel
activ
effect
atp
block
pretreament
sb
transfect
dominantneg
mapk
kinas
transfect
show
obviou
decreas
pass
matrigelco
membran
well
activ
compar
transfect
map
kinas
phosphatas
novel
mkp
inactiv
sapkjnk
mapkerk
also
found
incit
cancer
invas
inhibit
atpinduc
activ
corollari
activ
downstream
transduct
pathway
receptor
might
great
import
promot
prostat
cancer
invas
impli
signific
potenti
therapeut
target
cancer
studi
reveal
matrix
metalloproteinas
mmp
tissu
inhibitor
metalloproteas
might
particip
atpinduc
cancer
invas
express
influenc
atp
cell
sever
acut
respiratori
syndrom
sar
catastroph
spring
worldwid
particularli
china
singapor
canada
professor
mingpeng
chines
academi
medic
scienc
peke
union
medic
colleg
china
report
sar
model
macaca
mulata
rhesu
monkey
gener
give
sar
coviru
lung
tissu
lysat
patient
die
sar
via
nasal
caviti
bronchu
intraven
assess
clinic
symptom
anal
temperatur
blood
white
count
virolog
assay
viru
antibodi
detect
rtpcr
coronaviru
cultiv
systemat
patholog
chang
observ
day
viru
inocul
definit
acut
haemorrhag
interstiti
pneumonia
seen
monkey
day
viru
inocul
follow
lesion
acut
interstiti
bronchial
pneumonia
monkey
day
viru
infect
even
day
viru
inocul
patholog
chang
includ
destruct
elast
fibr
septa
commun
neighbour
air
sac
expans
alveoli
chronic
pleuriti
still
appear
monkey
number
infiltr
cell
decreas
day
day
viru
infect
hyalin
membran
desquam
line
cell
seen
damag
alveoli
remark
describ
human
autopsi
find
addit
lung
pleural
lesion
congest
red
pulp
spleen
prolifer
epitheli
endotheli
cell
renal
glomeruli
focal
liver
necrosi
also
discov
sar
develop
professor
bingquan
wu
peke
univers
china
introduc
method
gene
detect
sar
coronaviru
broad
applic
clinic
diagnosi
surveil
investig
devis
pair
primer
probe
molecular
beacon
specif
recognit
highli
conserv
region
sarsrel
coronaviru
polymeras
gene
sequenc
obtain
genebank
realtim
rtpcr
assay
extent
sarsrel
coronaviru
amplif
measur
term
increas
fluoresc
amplif
process
fragment
pcr
product
confirm
use
convent
pcr
assay
prove
use
dna
sequenc
ident
target
sequenc
probe
hybridis
clinic
specimen
patient
suspect
sar
sar
postmortem
case
epidem
beij
sarsrel
coronaviru
identifi
use
method
professor
thoma
kirchner
univers
erlangennuremberg
germani
show
group
recent
studi
colorect
cancer
progress
colorect
cancer
nonlinear
driven
morphogenet
program
deriv
normal
develop
gastrul
import
molecul
wnt
signal
pathway
promin
nuclear
stain
invas
front
usual
epitheli
mesenchym
transit
centr
tumour
implic
critic
role
morphogenesi
upregul
downstream
target
gene
includ
upa
etc
studi
invasionassoci
gene
express
profil
colorect
cancer
affymetrix
chip
contain
gene
disclos
intratumour
heterogen
colorect
carcinoma
gene
found
invas
front
gene
could
separ
three
subgroup
includ
aforement
known
target
gene
lymphocyt
gene
factor
angiogenesi
gene
express
profil
defin
identifi
target
interfer
morphogenesi
colorect
cancer
progress
microsatellit
instabl
account
colorect
carcinogenesi
comparison
microsatellit
stabil
microsatellit
instabl
msi
l
cancer
msih
colorect
cancer
frequent
associ
right
hemicolon
locat
mucin
signet
ring
cell
cribriform
medullari
subtyp
promin
intraepitheli
lymphocyt
crohn
slike
reaction
frameshift
mutat
transform
growth
factor
tgf
insulinlik
growth
factor
igf
iir
bax
rel
better
prognosi
despit
poor
differenti
msih
colorect
cancer
could
occur
famili
hereditari
nonpolyposi
colon
cancer
hnpcc
sporad
set
differ
clinicopatholog
molecular
featur
discov
two
parallel
pathway
hnpcc
cancer
display
germlin
mutat
mismatch
gene
mainli
associ
tradit
sequenc
less
concurr
serrat
adenoma
mucin
adenocarcinoma
wherea
sporad
msih
cancer
characteris
hypermethyl
promot
region
methyl
phenotyp
associ
serrat
pathway
concurr
serrat
adenoma
mucin
adenocarcinoma
professor
kirchner
also
introduc
three
new
rout
colorect
carcinogenesi
serrat
rout
juvenil
polyp
rout
colitisdysplasiacarcinoma
rout
infer
new
world
health
organ
classif
tumour
digest
system
addit
tradit
rout
multigen
multistep
process
accumul
mutationsloss
heterozygos
loh
etc
wide
accept
tradit
sequenc
nevertheless
combin
mutat
could
interpret
colorect
cancer
impli
presenc
molecular
model
accumul
evid
suggest
msi
might
critic
serrat
pathway
addit
increas
frequenc
serrat
polyp
adenoma
adjac
sporad
msih
colorect
cancer
molecular
alter
includ
inactiv
shift
mutat
bax
igfiir
also
uncov
ulcer
coliti
patient
develop
colon
cancer
year
year
respect
invas
could
occur
intraepitheli
neoplasia
ulcer
coliti
exhibit
rel
mild
morpholog
chang
criteria
highgrad
intraepitheli
neoplasia
complic
coliti
less
sever
adenoma
dysplasiaassoci
lesion
mass
dalm
highgrad
flat
dysplasia
commonli
associ
concurr
invas
cancer
frequent
lead
total
colonectomi
henc
discrimin
sporad
adenoma
dalm
pivot
despit
frequent
villou
structur
high
nuclear
low
nuclear
dalm
discrimin
remain
difficult
identif
new
molecular
marker
associ
colorect
adenoma
cancer
may
uncov
critic
event
involv
initi
progress
colorect
cancer
may
great
signific
prevent
diagnosi
treatment
cancer
professor
lai
group
done
intrigu
work
field
gener
three
differenti
express
cdna
librari
patient
colon
adenomanorm
mucosa
tn
colon
adenocarcinomanorm
mucosa
ta
colon
adenocarcinomaadenoma
use
suppress
subtract
hybridis
method
clone
obtain
librari
tn
ta
insert
sequenc
clone
amplifi
verifi
mean
revers
northernblot
techniqu
use
digoxigenin
dig
label
probe
great
number
gene
separ
known
gene
hypothet
protein
novel
gene
unknown
express
sequenc
tag
est
obtain
tradit
method
sequenc
est
assembl
blastn
public
databas
combin
bioinformat
analysi
base
selfdevis
linuxbas
platform
analys
nucleic
sequenc
automat
unknown
est
sequenc
submit
genebank
known
gene
found
associ
import
biolog
function
fundament
associ
cytoskeleton
cell
cycl
prolifer
immun
metabol
signal
transduct
pathway
two
candid
gene
regiv
investig
known
sequenc
gene
separ
tn
librari
combin
sequenc
rapid
amplif
cdna
end
product
sequenc
bp
obtain
share
ident
indic
gene
semiquantit
rtpcr
immunohistochemistri
use
detect
express
colorect
cancer
tissu
cell
line
lovo
level
mrna
express
high
colorect
carcinoma
moder
adenoma
tissu
adjac
tumour
low
normal
tissu
express
found
five
cell
line
except
immunostain
stronger
cancer
tissu
pair
normal
tissu
stronger
stain
seen
invas
front
cancer
centr
cancer
also
associ
increas
frequenc
lymphnod
involv
deeper
invas
stronger
stain
remain
cancer
explor
uncov
fast
glucos
level
significantli
correl
express
cancer
tissu
conclus
overexpress
might
play
import
role
initi
progress
colorect
cancer
may
link
increas
potenti
invas
express
may
also
associ
fast
glucos
level
presenc
diabet
mellitu
regiv
novel
gene
first
isol
larg
inflammatori
bowel
diseas
librari
obtain
librari
manner
contig
assembl
use
electron
clone
silico
clone
est
databas
semiquantit
rtpcr
colorect
adenoma
concurr
carcinoma
indic
reg
iv
mrna
level
higher
adenoma
concurr
colorect
carcinoma
compar
pair
normal
colorect
mucosa
northernblot
analysi
support
find
subsequ
studi
situ
hybridis
diglabel
crna
colorect
adenoma
vari
degre
dysplasia
disclos
reg
iv
overexpress
adenoma
mild
moder
dysplasia
case
adenoma
sever
dysplasia
compar
pair
normal
tissu
addit
higher
level
reg
iv
mrna
consist
score
region
sever
dysplasia
within
adenoma
sampl
display
vari
degre
dysplasia
strongest
stain
seen
within
carcinomat
area
adenoma
case
result
support
overexpress
reg
iv
may
earli
event
colorect
carcinogenesi
detect
reg
iv
overexpress
may
use
earli
assess
carcinomat
transform
adenoma
professor
lirong
chen
zhejiang
univers
china
explor
histogenesi
neural
differenti
gastrointestin
stromal
tumour
gist
ckit
use
electron
microscopi
immunocytochemistri
ultrastructur
featur
neural
differenti
observ
gist
myogen
differenti
gist
neither
gist
among
gist
ultrastructur
featur
neural
differenti
posit
neuronspecif
enolas
nse
case
posit
respect
henc
gastrointestin
autonom
nerv
tumour
regard
subtyp
gist
due
overlap
morpholog
featur
gist
accompani
neural
differenti
professor
harald
stein
univers
germani
introduc
develop
histori
gener
featur
present
classif
lymphoid
tumour
discuss
recent
molecular
issu
nonhodgkin
lymphoma
achiev
intern
standard
assess
diagnost
valu
igh
rearrang
collabor
studi
european
institut
includ
pcr
laboratori
seven
nation
network
carri
gastric
biopsi
histolog
diagnos
reassess
seven
pathologist
without
knowledg
pcr
result
meanwhil
igh
pcr
analysi
done
without
knowledg
histolog
diagnos
use
three
igh
primer
monoclon
igh
identifi
gastriti
case
borderlin
case
mucosaassoci
lymphoid
tissu
malt
lymphoma
respect
thu
professor
stein
conclud
distinct
true
clonal
pseudoclon
essenti
correct
interpret
possibl
pcr
assay
repeat
least
two
time
use
primer
high
qualiti
mantl
cell
lymphoma
mcl
uniqu
small
cell
lymphoma
poor
prognosi
characteris
cyclin
overexpress
result
lead
ighcyclin
protein
howev
mcl
gene
express
signatur
defin
larg
subset
mcl
express
cyclin
novel
subset
lack
express
year
median
surviv
better
cyclin
mcl
cyclin
mcl
furthermor
gene
express
profil
leukaem
mcl
cell
otherwis
ident
mcl
compar
studi
among
mcl
cell
line
leukaem
mcl
cell
nodal
mcl
cell
three
chromosom
aberr
trisomi
found
fraction
gastric
malt
lymphoma
demonstr
studi
molecularcytogenet
comparison
malt
lymphoma
larg
bcell
lymphoma
propos
malt
lymphoma
separ
differ
genet
subgroup
furthermor
clonal
lymphoma
progress
occur
small
larg
cell
compon
identifi
accumul
gain
loss
chromosom
materi
larg
cell
compon
malt
lymphoma
plu
larg
bcell
lymphoma
aberr
overlap
malt
lymphoma
malt
lymphoma
plu
larg
bcell
lymphoma
includ
loss
chromosom
amplif
rel
protooncogen
gain
chromosom
addit
largecel
compon
reveal
gain
includ
amplif
myc
protooncogen
loss
larg
bcell
lymphoma
frequent
gain
chromosom
well
loss
diffus
largecel
bcell
lymphoma
dcbcl
one
complic
lymphoid
tumour
entiti
mani
morpholog
variant
type
recent
three
geneexpress
bcelllik
gcb
type
activ
bcelllik
abc
type
identifi
dna
microarray
analysi
dlbcl
among
patient
gcb
subgroup
highest
surviv
rate
anoth
microarray
studi
focus
centroblast
lymphoma
cbl
burkitt
lymphoma
confirm
dlbcl
centroblast
morpholog
separ
gcb
type
abc
type
howev
cbl
abc
type
burkitt
lymphoma
gcb
type
contrast
studi
latter
differ
probabl
due
highli
variabl
percentag
tumour
cell
biopsi
reliabl
distinct
primari
mediastin
thymic
larg
bcell
lymphoma
pmlbcl
common
type
dlbcl
obtain
via
clinic
inform
howev
distinct
reliabl
made
gene
express
profil
without
clinic
inform
intriguingli
pmlbcl
share
sever
featur
downregul
resembl
classic
hodgkin
lymphoma
anoth
rare
entiti
dlbcl
plasmablast
lymphoma
also
distinguish
dlbcl
abc
type
gcb
type
gene
express
profil
thu
close
report
professor
stein
conclud
new
scientif
data
integr
classif
concept
would
lead
identif
new
lymphoma
diseas
sharpen
exist
definit
professor
gandi
li
sichuan
univers
china
investig
intestin
tcell
lymphoma
itcl
chines
includ
broad
pattern
clinicopatholog
featur
molecular
alter
neither
immunosuppress
clinic
evid
celiac
diseas
time
diagnosi
implic
patient
prognosi
gener
poor
indic
short
relaps
period
patient
relaps
within
month
surviv
time
patient
die
median
surviv
month
despit
fact
patient
one
site
involv
surviv
month
comparison
enteropathytyp
intestin
tcell
lymphoma
etcl
itcl
unusu
clinic
featur
male
predilect
young
age
mean
year
predominantli
ileocecum
colon
locat
histolog
pattern
similar
itcl
etcl
except
massiv
zonal
necrosi
absenc
enteropathi
seen
itcl
immunophenotyp
viru
ebv
detect
show
similar
pattern
found
nasal
nkt
cell
lymphoma
includ
invari
eber
owe
peculiar
ebvassoci
entiti
distinct
clinicopatholog
featur
itcl
chines
put
catalogu
separ
etcl
professor
weip
liu
sichuan
univers
china
studi
case
nasal
nktcell
lymphoma
routin
diagnost
protocol
nasal
nktcell
lymphoma
put
forward
includ
morpholog
featur
massiv
coagul
necrosi
mostli
mediums
atyp
cell
increas
vessel
immunophenotyp
display
granzym
b
eber
use
situ
hybridis
address
eber
situ
hybridis
sensit
method
ebv
detect
lymphoma
paraffin
tissu
pcr
immunostain
followup
studi
case
reveal
gener
surviv
rate
nktcell
lymphoma
respect
lower
tumour
stage
free
recurr
combin
therapi
favour
prognost
stagei
ii
tumour
surviv
rate
respect
comparison
stageiii
iv
tumour
nude
mous
model
cell
line
nktcell
lymphoma
success
gener
secondari
lymphoma
stomach
might
great
signific
studi
tumour
afterward
cdna
microarray
analysi
lymphoma
carri
total
differenti
express
gene
identifi
upregul
downregul
preliminari
assess
suggest
downregul
upregul
gene
might
close
correl
nasal
nktcell
lymphoma
professor
manfr
dietel
berlin
germani
gave
overal
aspect
consider
improv
classif
gynaegolog
tumour
comparison
version
explain
chang
diagnost
terminolog
new
classif
import
exampl
former
categori
epitheli
tumour
borderlin
malign
low
malign
potenti
condens
term
borderlin
tumour
term
low
malign
potenti
avoid
due
consider
misunderstand
among
pathologist
clinician
result
distinct
overtherapi
serou
borderlin
tumour
ovari
particularli
address
immunohistochemistri
well
new
diagnost
procedur
dna
cytophotometri
recommend
assess
invas
foci
diagnosi
serou
borderlin
tumour
microinvas
although
prognost
relev
attribut
microinvas
new
type
micropapillari
serou
borderlin
tumour
mention
fulli
accept
surfac
prolifer
periton
implant
common
serou
borderlin
tumour
howev
invas
destruct
implant
associ
unfavour
outcom
wherea
surfac
prolifer
per
se
noninvas
periton
implant
strikingli
correl
poor
prognosi
therefor
address
periton
implant
distinguish
invas
noninvas
type
accord
criteria
recommend
regard
endometri
carcinoma
type
ii
separ
due
differ
clinicopatholog
featur
typei
cancer
lowgrad
prototyp
endometrioid
adenocarcinoma
associ
exogen
endogen
hyperoestron
endometri
hyperplasia
particular
atyp
hyperplasia
rel
good
clinic
prognosi
higher
oestrogen
receptor
progesteron
receptor
overexpress
wherea
typeii
carcinoma
exhibit
aggress
behaviour
primarili
elderli
patient
higher
overexpress
threetier
grade
system
adopt
typei
endometri
carcinoma
base
compon
solid
growth
pattern
without
glandular
format
also
supplement
solid
nest
cell
show
squamou
morular
differenti
increas
tumour
grade
bizarr
nuclear
atypia
rais
grade
one
type
eg
new
classif
defin
endometri
intraepitheli
neoplasia
uterin
corpu
howev
limit
experi
clinic
implement
present
time
addit
cervic
squamou
cell
carcinoma
microinvas
distinguish
highgrad
cervic
intraepitheli
neoplasia
cin
uterin
cervix
earli
invas
indic
matur
squamou
cell
extend
focu
situ
carcinoma
lumin
necrosi
intraepitheli
squamou
matur
well
stromal
oedema
stromal
desmoplast
lymphocyt
respons
featur
aid
distinct
crypt
involv
cin
regard
cin
system
increas
tendenc
use
twotier
classif
low
highgrad
cin
equat
cin
versu
cin
respect
classif
tumor
p
intern
feder
gynecolog
obstetr
definit
carcinoma
cervix
outlin
depth
invas
may
greater
mm
horizont
spread
measur
mm
less
professor
joachim
diebold
ludwigmaximiliansunivers
germani
focus
select
issu
concern
classif
ovarian
tumour
classif
mucin
tumour
classif
extraovarian
lesion
associ
serou
tumour
classif
primari
extraovarian
periton
serou
tumour
threetier
grade
system
ovarian
carcinoma
score
growth
pattern
nuclear
pleomorph
mitot
activ
recommend
new
classif
propos
silverberg
promin
prognost
signific
silverberg
grade
disclos
multivari
cox
analysi
howev
list
clear
cell
carcinoma
mucin
carcinoma
grade
due
absenc
prognost
andor
therapeut
relev
endometrioid
carcinoma
transit
carcinoma
grade
use
criteria
endometri
carcinoma
transit
carcinoma
urinari
tract
mucin
adenocarcinoma
ovari
rare
despit
presenc
mani
subtyp
emphasis
mucin
metastas
ovari
colorect
appendic
gastric
pancreaticobiliari
endocerv
carcinoma
common
primari
ovarian
mucin
carcinoma
differenti
diagnosi
may
extrem
difficult
due
share
gross
microscop
featur
overlap
immunophenotyp
two
subtyp
mucin
borderlin
tumour
ovari
endocerv
type
intestin
type
differ
clinic
morpholog
featur
intraepitheli
carcinoma
defin
presenc
area
sever
atypia
three
cell
layer
intestin
type
mucin
borderlin
tumour
extraovarian
lesion
associ
serou
tumour
uncommon
clinicopatholog
featur
similar
ovarian
counterpart
particular
attent
paid
mullerian
inclus
cyst
potenti
diagnost
pitfal
due
presenc
pelvic
paraaort
lymph
node
accord
recent
report
primari
periton
serou
carcinoma
rare
carcinoma
defin
use
histolog
indistinguish
primari
ovarian
carcinoma
normals
ovari
review
molecular
approach
gynaecolog
tumour
professor
diebold
conclud
molecular
basi
multistep
process
neoplast
transform
establish
gynaecolog
carcinoma
genet
chang
identifi
far
partial
explain
phenotyp
variabl
gynaecolog
tumour
typei
endometri
carcinoma
good
exampl
paradigm
multistep
carcinogenesi
process
transform
normal
endometrium
simpl
hyperplasia
complex
hyperplasia
lowgrad
highgrad
carcinoma
estrogen
stimul
underli
genet
alter
includ
microsatellit
instabl
mutat
involv
pten
kra
etc
accumul
specif
msih
endometri
carcinoma
associ
mucin
differenti
favour
prognosi
pten
mutat
use
compar
genom
hybrid
cgh
array
accumul
genet
aberr
also
found
transform
serou
borderlin
tumour
invas
serou
carcinoma
rare
event
genet
aberr
endometri
ovarian
tumour
affect
member
signal
pathway
growth
factor
receptor
regulatori
molecul
cell
cycl
differenti
apoptosi
activ
member
ra
wnt
pathway
frequent
typei
endometri
carcinoma
exampl
kra
mutat
found
typei
endometri
carcinoma
respect
sever
gene
signal
pathway
receptor
tyrosin
kinas
frequent
activ
epitheli
ovarian
tumour
includ
ra
raf
pten
etc
moreov
serou
borderlin
tumour
characteris
activ
rasbraf
pathway
suggest
differ
molecular
development
pathway
contrast
invas
serou
carcinoma
professor
diebold
also
discuss
role
chromosom
ovarian
carcinogenesi
harbour
high
densiti
put
relev
gene
etc
studi
prove
gain
transcript
factor
use
fluoresc
situ
hybridis
fish
reduc
overexpress
unfavour
prognost
factor
ovarian
carcinoma
professor
ferdinand
univers
regensburg
germani
compar
classif
tumour
urinari
system
version
focus
sever
topic
regard
urotheli
tumour
base
molecular
clinic
data
urotheli
tumour
separ
infiltr
tumour
defin
urotheli
tumour
invad
beyond
basement
membran
noninvas
tumour
papilloma
papillari
urotheli
neoplasm
lowmalign
potenti
punlmp
noninvas
cancer
includ
punlmp
suppos
carri
label
cancer
twotier
grade
system
urotheli
epitheli
cancer
lowhigh
grade
substitut
former
threetier
system
avoid
diagnosi
case
previous
classif
flat
lesion
independ
type
comprehens
entiti
exhibit
hyperplasia
reactiv
atypia
atypia
unknown
signific
dysplasia
lowgrad
intraurotheli
neoplasia
carcinoma
situ
hyperplasia
dysplasia
precursor
lesion
urotheili
tumour
might
repres
two
differ
pathway
carcinogenesi
papillari
invas
pathway
papillari
pathway
genet
stabl
case
associ
frequent
whole
chromosom
loss
rare
genet
alter
whearea
invas
pathway
genet
unstabl
frequent
show
mutat
lesion
cancer
patient
may
clonal
relat
respect
tumour
indic
ident
pattern
loh
analysi
delet
fish
well
duplic
mutat
sequenc
hyperplasiapapillomarecurr
papilloma
dysplasia
carcinoma
situ
patient
oligoclon
monoclon
multifoc
carcinoma
also
discov
use
similar
method
support
intralumin
dissemin
multifoc
cancer
professor
also
report
role
msi
chromosom
delet
sever
candid
gene
eg
loss
express
found
urotheli
carcinoma
associ
papillari
growth
pattern
lower
surviv
rate
patient
invas
papillari
tumour
despit
fact
mutat
code
sequenc
promot
region
identifi
urotheli
carcinoma
loss
five
cell
line
well
rare
promot
methyl
cdnaarray
express
analysi
might
benefici
sharper
tumour
classif
urotheli
tumour
manner
hierarch
cluster
gene
express
analysi
found
contribut
discrimin
noninvas
invas
papillari
tumour
via
differenti
express
gene
professor
otmar
wiestler
german
cancer
research
center
heidelberg
germani
address
major
chang
new
classif
brain
tumour
includ
new
tumour
entiti
variant
detail
criteria
diagnosi
tumour
grade
molecular
genet
alter
list
astrocyt
neoplasm
pilocyt
astrocytoma
diffus
lowgrad
astrocytoma
anaplast
astrocytoma
glioblastoma
multiform
gbm
regard
grade
ii
iii
iv
respect
tanycyt
ependymoma
pineal
parenchym
tumour
intermedi
differenti
larg
cell
medulloblastoma
rhabdoid
meningioma
teratoma
malign
transform
novel
tumour
variant
new
fascicl
wherea
polar
spongioblastoma
cyst
tumourlik
lesion
rathk
cyst
nasal
glioma
local
invad
cancer
mention
pituitari
adenoma
put
anoth
fascicl
also
review
recent
molecular
advanc
brain
tumour
two
differ
genet
pathway
lead
gbm
type
primari
de
novo
precursor
cell
type
ii
secondari
progress
lowgrad
astrocytoma
except
pilocyt
astrocytoma
associ
indol
biolog
behaviour
rare
progress
amplif
egfr
chromosom
loh
common
tumorigenesi
gbm
loh
well
loh
common
typeii
gbm
dna
aberr
methyl
might
also
play
import
role
initi
develop
glioma
studi
gbm
oligodendroglioma
pilocyt
astrocytoma
use
dmh
cpg
chip
tumour
methylationspecif
pattern
obtain
help
histopatholog
diagnosi
also
guid
identif
multipl
novel
candid
gene
loh
frequent
involv
oligodendrogli
tumour
loh
incid
loci
found
higher
oligodendroglioma
ii
anaplast
oligodendroglioma
iii
implic
prognost
signific
classic
desmoplast
medulloblastoma
differ
tumourigenesi
classic
associ
loh
myc
amplif
desmoid
associ
loh
ptch
inactiv
overexpress
cmyc
may
relat
unfavour
prognosi
medulloblastoma
patient
recent
studi
tumour
also
demonstr
express
profil
via
cdna
array
chip
make
desmoplast
classic
medulloblastoma
distinguish
professor
iver
petersen
berlin
germani
report
chang
new
lung
cancer
classif
incorpor
clinic
data
epidemiolog
sign
symptom
imag
prognosi
particular
genet
characterist
still
morpholog
defin
subtyp
predict
factor
subdivid
clinic
histopatholog
genet
paramet
howev
open
window
new
subent
gener
speak
morpholog
subtyp
remain
essenti
unchang
issu
morpholog
heterogen
phenotyp
transit
still
contenti
practic
ground
minim
compon
gener
requir
diagnos
mix
tumour
entiti
adenosquam
carcinoma
pleomorph
carcinoma
combin
small
carcinoma
larg
cell
compon
variant
squamou
cell
carcinoma
scc
addit
mention
ie
scc
resembl
transit
cell
carcinoma
alveoloar
spacefil
type
peripher
scc
grow
without
destruct
alveolar
framework
repres
peripher
scc
latter
contrast
convent
expand
type
scc
show
infiltr
destruct
normal
lung
architectur
spindl
cell
scc
group
sarcomatoid
carcinoma
adenocarcinoma
noguchi
subtyp
defin
mixtur
gross
histolog
featur
mention
includ
type
localis
bronchioloalveolar
carcinoma
type
b
localis
bronchioloalveolar
carcinoma
central
alveolar
collaps
type
c
localis
bronchioloalveolar
carcinoma
fibroblast
prolifer
type
poorli
differenti
adenocarcinoma
type
e
tubular
adenocarcinoma
type
f
papillari
adenocarcinoma
compress
growth
pattern
type
great
signific
assess
clinic
treatment
prognosi
six
type
type
b
thought
situ
peripher
adenocarcinoma
show
lymphnod
metastasi
favour
prognosi
surviv
thu
cancer
may
potenti
cure
limit
resect
eg
wedg
resect
howev
diagnosi
need
good
comput
tomographi
correl
requir
entir
section
histolog
convers
type
c
appear
advanc
stage
type
b
wherea
type
e
f
small
advanc
adenocarcinoma
less
favour
prognos
professor
petersen
also
document
molecular
pattern
analysi
dna
rna
protein
level
use
cgh
arraycgh
cdnaoligomicroarray
mass
spectrometri
express
analysi
may
abl
refin
morpholog
tumour
classif
cdna
array
studi
lung
cancer
normal
lung
gene
express
pattern
segreg
four
major
morpholog
subtyp
lung
tumour
also
provid
gene
cluster
characterist
adenocarcinoma
subgroup
morpholog
surviv
differ
furthermor
express
profil
larg
cell
lung
cancer
suggest
transit
protein
analysi
use
matrixassist
laser
desorptionionis
timeofflight
reveal
proteom
pattern
lung
cancer
could
classifi
correctli
primari
nonsmal
cell
lung
cancer
nsclc
normal
lung
sampl
accord
ms
peak
also
discrimin
primari
nsclc
metastas
recurr
lung
tumour
indic
distinct
ms
peak
six
group
lung
cancer
prognost
differ
gener
analys
proteom
pattern
ms
peak
professor
christian
wittekind
leipzig
univers
germani
summaris
improv
edit
intern
union
cancer
uicc
tumour
node
metastasi
tnm
classif
malign
tumour
gave
overview
chang
differ
tumour
entiti
list
classif
made
comment
import
clinic
use
r
classif
introduc
describ
absenc
presenc
residu
tumour
treatment
three
descriptor
design
residu
tumour
microscop
residu
tumour
macroscop
residu
tumour
exampl
gastrectomi
specimen
circumferenti
resect
margin
crm
consid
margin
minor
ligament
gastrocol
mesocol
ligament
hepatoduoden
ligament
subseros
soft
tissu
nonperitonealis
region
accord
data
residu
tumour
gastric
carcinoma
resect
specimen
erlangen
cancer
center
patient
crm
frequent
involv
sentinel
lymph
node
first
lymph
node
receiv
lymphat
drainag
primari
tumour
good
indic
lymphnod
metastasi
occasion
one
sentinel
lymph
node
follow
design
applic
sentinel
lymph
node
assess
attempt
pnx
sn
sentinel
lymph
node
could
node
assess
sn
sentinel
lymph
node
metastasi
sn
sentinel
lymph
node
metastasi
isol
tumour
cell
itc
singl
tumour
cell
small
cluster
cell
mm
greatest
dimens
micrometastasi
cm
usual
detect
use
immunohistochemistri
molecular
method
howev
itc
typic
show
evid
metastat
activ
eg
prolifer
stromal
reaction
penetr
vascular
lymphat
sinu
wall
explain
develop
tnm
system
exampl
colorect
carcinoma
mention
stage
iii
separ
stage
iiia
iiib
iiic
surviv
rate
respect
final
address
tnm
system
variabl
essenti
import
prognost
factor
addit
wellestablish
factor
uicc
also
consid
spectrum
prognost
factor
new
public
includ
new
promis
molecular
marker
